Myeloid/lymphoid neoplasm with ZMYM2::FGFR1 rearrangement: A complex trilineage phenotypic and clonal evolution with associated genomic alterations

[1]  Y. Natkunam,et al.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms , 2022, Leukemia.

[2]  Yuan Chen,et al.  Acute Mast Cell Leukemia Preceded by Malignant Mediastinal Germ Cell Tumor: A Case Report and Literature Review , 2022, Cancer management and research.

[3]  S. Verstovsek,et al.  A Phase 2 Study of Pemigatinib (FIGHT-203; INCB054828) in Patients with Myeloid/Lymphoid Neoplasms (MLNs) with Fibroblast Growth Factor Receptor 1 (FGFR1) Rearrangement (MLN FGFR1) , 2021, Blood.

[4]  Sharon Koorse Germans,et al.  Myeloid/lymphoid neoplasm with FGFR1 rearrangement. , 2021, Blood.

[5]  Steven J. M. Jones,et al.  The genetic basis and cell of origin of mixed phenotype acute leukaemia , 2018, Nature.

[6]  P. A. Futreal,et al.  Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes , 2018, Nature Communications.

[7]  V. Najfeld,et al.  Myeloid/lymphoid neoplasms with FGFR1 rearrangement , 2018, Leukemia & lymphoma.

[8]  T. Haferlach,et al.  Molecular genetic characterization of myeloid/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 or PCM1-JAK2 , 2018, Haematologica.

[9]  Chung-Wu Lin,et al.  FGFR1 translocation with concurrent myeloproliferative neoplasm, systemic mastocytosis, and lymphoblastic lymphoma: a case report. , 2017, Human pathology.

[10]  N. Sorel,et al.  Unique association of systemic mastocytosis and myeloid/lymphoid neoplasm in blast crisis with abnormality of FGFR1 gene. , 2012, Leukemia research.